Get notified when RZLT files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: RZLT Rezolute, Inc. 8-K

Rezolute announces interim update on upLIFT clinical study

Filed June 2, 2026 · Period ending June 2, 2026 · ~1 min read

Key Changes

  • medium

    Company issued press release with interim data from its upLIFT study, though specific results and findings were not disclosed in the 8-K filing itself.

    Item 7.01 verify on EDGAR →
  • low

    Filing made under Regulation FD Disclosure rules, indicating the company is broadly disseminating information to comply with fair disclosure requirements.

    Item 7.01 verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (PXED 10-Q) is open in full — no account needed.

Partner

Trade RZLT commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov Press release (Ex 99.1) on EDGAR ↗

Source-verified from EDGAR · Narrative written by AI · Jun 3, 2026 · How we verify